A Study to Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and in 1st Line Negative Unresectable, Recurrent or Metastatic Gastric or of Gastroesophageal Junction (GEJ)

  • Cancer
  • Gastric and Gastroesophageal Junction Carcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Gastric Cancer
  • Tumor
  • Neoplasms
  • Stomach Neoplasms